CLINICAL PHARMACOKINETICS OF ALLOPURINOL

被引：115

作者：

MURRELL, GAC ^{[1
]}

RAPEPORT, WG ^{[1
]}

机构：

[1] UNIV OXFORD,DEPT CLIN PHARMACOL,MRC UNIT,OXFORD,ENGLAND

来源：

关键词：

D O I：

10.2165/00003088-198611050-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：343 / 353

页数：11

共 38 条

[1] APPELBAUM SJ, 1982, CANC CHEMOTHER PHARM, V14, P789
[2] BENEZRA SA, 1978, ANAL PROFILES DRUG S, V7, P1
[3] THE EFFECT OF DIETARY-PROTEIN ON THE CLEARANCE OF ALLOPURINOL AND OXYPURINOL
BERLINGER, WG
PARK, GD
SPECTOR, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) : 771 - 776
[4] IDENTIFICATION OF HYPOXANTHINE TRANSPORT AND XANTHINE-OXIDASE ACTIVITY IN BRAIN CAPILLARIES
BETZ, AL
[J]. JOURNAL OF NEUROCHEMISTRY, 1985, 44 (02) : 574 - 579
[5] CASKEY CT, 1964, J BIOL CHEM, V239, P2570
[6] BIOAVAILABILITY OF ALLOPURINOL ORAL AND RECTAL DOSAGE FORMS
CHANG, SL
KRAMER, WG
FELDMAN, S
BALLENTINE, R
FRANKEL, LS
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (03): : 365 - 368
[7] EDWARDS NL, 1981, J LAB CLIN MED, V98, P673
[8] RENAL CLEARANCE OF OXIPURINOL CHIEF METABOLITE OF ALLOPURINOL
ELION, GB
YU, TF
GUTMAN, AB
HITCHINGS, GH
[J]. AMERICAN JOURNAL OF MEDICINE, 1968, 45 (01) : 69 - +
[9] ELION GB, 1966, BIOCHEM PHARMACOL, V15, P836
[10] ELION GB, 1980, ADV EXPT BIOL MED, V1224, P263